Form 4: Guardant Health CFO Sells Shares After Option Exercise

Guardant Health's Chief Financial Officer, Michael Brian Bell, exercised stock options and subsequently sold a significant number of common shares.

Summary

• Michael Brian Bell, Chief Financial Officer of Guardant Health, Inc. (GH), engaged in multiple transactions on December 5, 2025.
• Exercised stock options to acquire a total of 56,287 shares (29,382 shares at $32.86 and 26,905 shares at $28.37).
• Sold a total of 80,362 shares of common stock at weighted average prices ranging from $101.4236 to $107.2625.
• The transactions were conducted pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
• Following these transactions, Bell's direct beneficial ownership of common stock decreased to 28,052 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider selling by a key executive, even though it was pre-planned. While the executive realized substantial gains, the net reduction in holdings can be perceived as a lack of strong conviction in the company's near-term stock appreciation.

Positives

• The CFO realized substantial gains by exercising stock options at significantly lower prices ($28.37 and $32.86) compared to the sale prices (over $100 per share).
• The transactions were executed under a Rule 10b5-1(c) plan, suggesting pre-scheduled sales rather than a reaction to immediate company performance or news.

Negatives

• Significant insider selling by a key executive (CFO) could be perceived negatively by investors, potentially signaling a lack of confidence or a belief that the stock price is near its peak.
• The total number of shares sold (80,362) significantly exceeds the number of shares acquired through option exercise (56,287), leading to a net reduction of 24,075 shares in the CFO's direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May interpret the significant net insider selling as a negative signal, potentially leading to downward pressure on the stock price.
• Employees: No direct impact mentioned, but general market sentiment could affect employee morale if the stock price declines.

Key Dates

Recommendation

The significant net selling of shares by the Chief Financial Officer, even under a 10b5-1 plan, suggests that a key insider is taking profits and reducing their exposure to the company's stock. While the executive realized substantial gains, the market often views large insider sales as a bearish signal, indicating that the insider may believe the stock is fully valued or that future growth prospects may be limited. This action could lead to negative market sentiment and potential downward pressure on the stock price, making a 'sell' recommendation prudent for investors looking to avoid potential declines or reallocate capital.

Keywords

Guardant Health, GH, SEC Form 4, Insider Trading, Stock Options, Share Sale, CFO, Michael Brian Bell, Rule 10b5-1, Executive Compensation